Income Statement
Balance Sheet
Cash Flow
| Line Item | Q3 2025Sep 30, 2025 | Q2 2025Jun 30, 2025 | Q1 2025Mar 31, 2025 | Q4 2024Dec 31, 2024 | Q3 2024Sep 30, 2024 | Q2 2024Jun 30, 2024 |
|---|---|---|---|---|---|---|
| Total Revenue | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | -- |
| Operating Revenue | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | -- |
| Selling General And Administration | 457,282 | 668,750 | 89,206 | 145,143 | 38,740 | -- |
| General And Administrative Expense | 454,100 | 668,750 | 89,206 | 145,143 | 38,740 | -- |
| Operating Expense | 457,282 | 668,750 | 89,206 | 145,143 | 38,740 | -- |
| Operating Income | -457,282 | -668,750 | -89,206 | -145,143 | -38,740 | -- |
| EBIT | -469,350 | -668,750 | -89,206 | -145,143 | -838,740 | -- |
| Interest Expense | 2,733 | 419.00 | 737.00 | 796.00 | 796.00 | -- |
| Interest Expense Non Operating | 2,733 | 419.00 | 737.00 | 796.00 | 796.00 | -- |
| Net Interest Income | -2,733 | -419.00 | -737.00 | -796.00 | -796.00 | -- |
| Other Income Expense | -- | -- | -- | -- | -800,000 | -- |
| Special Income Charges | -5,900 | 0.00 | 0.00 | -- | -800,000 | 0.00 |
| Pretax Income | -472,083 | -669,169 | -89,943 | -145,939 | -839,536 | -- |
| Tax Effect Of Unusual Items | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | -- |
| Net Income From Continuing And Discontinued Operation | -472,083 | -669,169 | -89,943 | -145,939 | -839,536 | -- |
| Net Income From Continuing Operation Net Minority Interest | -472,083 | -669,169 | -89,943 | -145,939 | -839,536 | -- |
| Net Income Including Noncontrolling Interests | -472,083 | -669,169 | -89,943 | -145,939 | -839,536 | -- |
| Net Income Common Stockholders | -472,083 | -669,169 | -89,943 | -145,939 | -839,536 | -- |
| Net Income | -472,083 | -669,169 | -89,943 | -145,939 | -839,536 | -- |
| EBITDA | -469,350 | -668,750 | -89,206 | -145,143 | -838,740 | -- |
| Normalized EBITDA | -457,282 | -668,750 | -89,206 | -145,143 | -38,740 | -- |
| Basic EPS | -- | -0.01 | -0.00 | -0.00 | -- | -0.00 |
| Diluted EPS | -- | -0.01 | -0.00 | -0.00 | -- | -0.00 |
| Basic Average Shares | -- | 113.1M | 98.1M | 78.4M | -- | 75.4M |
| Diluted Average Shares | -- | 113.1M | 98.1M | 78.4M | -- | 75.4M |
| Total Unusual Items | -12,068 | 0.00 | 0.00 | -- | -800,000 | 0.00 |
| Total Unusual Items Excluding Goodwill | -12,068 | 0.00 | 0.00 | -- | -800,000 | 0.00 |
| Tax Rate For Calcs | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | -- |
| Normalized Income | -460,015 | -669,169 | -89,943 | -145,939 | -39,536 | -- |
| Diluted NI Availto Com Stockholders | -472,083 | -669,169 | -89,943 | -145,939 | -839,536 | -- |
| Impairment Of Capital Assets | 0.00 | 0.00 | 0.00 | -- | 800,000 | 0.00 |
| Net Income Continuous Operations | -472,083 | -669,169 | -89,943 | -145,939 | -839,536 | -- |
| Net Non Operating Interest Income Expense | -2,733 | -419.00 | -737.00 | -796.00 | -796.00 | -- |
| Other Gand A | 198,279 | 668,750 | 89,206 | 145,143 | 38,740 | -- |
| Total Expenses | 457,282 | 668,750 | 89,206 | 145,143 | 38,740 | -- |
| Line Item | Q3 2025Sep 30, 2025 | Q2 2025Jun 30, 2025 | Q1 2025Mar 31, 2025 | Q4 2024Dec 31, 2024 | Q3 2024Sep 30, 2024 | Q2 2024Jun 30, 2024 |
|---|---|---|---|---|---|---|
| Cash And Cash Equivalents | 5,487 | 9,668 | 50,056 | 268,539 | 2,435 | -- |
| Cash Cash Equivalents And Short Term Investments | 5,487 | 9,668 | 50,056 | 268,539 | 2,435 | -- |
| Cash Financial | 5,487 | 9,668 | 50,056 | 268,539 | 2,435 | -- |
| Current Assets | 5,487 | 9,668 | 50,056 | 268,539 | 2,435 | -- |
| Gross PPE | -- | -- | -- | -- | -- | 1.00 |
| Net PPE | 1.5M | 1.5M | 1.5M | 101,001 | 1.00 | -- |
| Total Non Current Assets | 1.5M | 1.5M | 1.5M | 101,001 | 1.00 | -- |
| Total Assets | 1.5M | 1.6M | 1.6M | 369,540 | 2,436 | -- |
| Current Debt | 17,734 | 17,318 | 16,898 | 31,161 | 27,365 | -- |
| Current Debt And Capital Lease Obligation | 17,734 | 17,318 | 16,898 | 31,161 | 27,365 | -- |
| Accounts Payable | 926,473 | 755,727 | 128,295 | 172,636 | 154,580 | -- |
| Payables | 1.1M | 893,619 | 265,258 | 369,599 | 308,042 | -- |
| Payables And Accrued Expenses | 1.1M | 893,619 | 265,258 | 369,599 | 308,042 | -- |
| Current Liabilities | 1.1M | 910,937 | 282,156 | 400,760 | 335,407 | -- |
| Total Non Current Liabilities Net Minority Interest | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | -- |
| Total Liabilities Net Minority Interest | 1.1M | 910,937 | 282,156 | 400,760 | 335,407 | -- |
| Common Stock | 6.0M | 6.1M | 6.1M | 4.7M | 4.2M | -- |
| Capital Stock | 6.0M | 6.1M | 6.1M | 4.7M | 4.2M | -- |
| Additional Paid In Capital | 548,938 | 196,284 | 196,284 | 196,284 | 196,284 | -- |
| Retained Earnings | -6.1M | -5.7M | -5.0M | -4.9M | -4.7M | -- |
| Common Stock Equity | 415,808 | 642,168 | 1.3M | -31,220 | -332,971 | -- |
| Stockholders Equity | 415,808 | 642,168 | 1.3M | -31,220 | -332,971 | -- |
| Total Equity Gross Minority Interest | 415,808 | 642,168 | 1.3M | -31,220 | -332,971 | -- |
| Total Capitalization | 415,808 | 642,168 | 1.3M | -31,220 | -332,971 | -- |
| Net Tangible Assets | 415,808 | 642,168 | 1.3M | -31,220 | -332,971 | -- |
| Tangible Book Value | 415,808 | 642,168 | 1.3M | -31,220 | -332,971 | -- |
| Working Capital | -1.1M | -901,269 | -232,100 | -132,221 | -332,972 | -- |
| Invested Capital | 433,542 | 659,486 | 1.3M | -59.00 | -305,606 | -- |
| Total Debt | 17,734 | 17,318 | 16,898 | 31,161 | 27,365 | -- |
| Net Debt | 12,247 | 7,650 | -- | -- | 24,930 | 17,971 |
| Share Issued | 113.9M | 113.1M | 113.1M | 91.6M | 75.4M | -- |
| Ordinary Shares Number | 113.9M | 113.1M | 113.1M | 91.6M | 75.4M | -- |
| Dueto Related Parties Current | 18,909 | 12,892 | 11,963 | 71,963 | 28,462 | -- |
| Other Current Borrowings | 17,734 | 17,318 | 16,898 | 31,161 | 27,365 | -- |
| Other Equity Interest | -- | -5,900 | -5,900 | -5,900 | -- | -- |
| Other Payable | 125,000 | 125,000 | 125,000 | 125,000 | 125,000 | -- |
| Preferred Stock | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | -- |
| Properties | -- | -- | -- | -- | -- | 1.00 |
| Line Item | Q3 2025Sep 30, 2025 | Q2 2025Jun 30, 2025 | Q1 2025Mar 31, 2025 | Q4 2024Dec 31, 2024 | Q3 2024Sep 30, 2024 | Q2 2024Jun 30, 2024 |
|---|---|---|---|---|---|---|
| Operating Cash Flow | -45,516 | -41,737 | -134,285 | -127,883 | -7,806 | -- |
| Cash Flow From Continuing Operating Activities | -45,516 | -41,737 | -134,285 | -127,883 | -7,806 | -- |
| Change In Working Capital | 170,746 | 627,432 | -44,342 | 18,056 | 31,730 | -- |
| Change In Payables And Accrued Expense | 170,746 | 627,432 | -44,342 | 18,056 | 31,730 | -- |
| Capital Expenditure | -- | -- | -9,935 | -51,000 | -- | -- |
| Purchase Of PPE | 0.00 | 0.00 | -9,935 | -51,000 | 0.00 | -- |
| Net PPE Purchase And Sale | 0.00 | 0.00 | -9,935 | -51,000 | 0.00 | -- |
| Investing Cash Flow | 0.00 | 0.00 | -9,935 | -51,000 | 0.00 | -- |
| Cash Flow From Continuing Investing Activities | 0.00 | 0.00 | -9,935 | -51,000 | 0.00 | -- |
| Issuance Of Debt | -- | -- | -- | -- | -- | 27,196 |
| Net Issuance Payments Of Debt | 416.00 | -- | -- | 3,796 | 6,688 | 27,196 |
| Issuance Of Capital Stock | 34,902 | 0.00 | 0.00 | 397,690 | 0.00 | -- |
| Net Common Stock Issuance | 34,902 | 0.00 | 0.00 | 397,690 | 0.00 | -- |
| Financing Cash Flow | 41,335 | 1,349 | -74,263 | 444,987 | 7,535 | -- |
| Cash Flow From Continuing Financing Activities | 41,335 | 1,349 | -74,263 | 444,987 | 7,535 | -- |
| Changes In Cash | -4,181 | -40,388 | -218,483 | 266,104 | -271.00 | -- |
| Beginning Cash Position | 9,668 | 50,056 | 268,539 | 2,435 | 2,706 | -- |
| End Cash Position | 5,487 | 9,668 | 50,056 | 268,539 | 2,435 | -- |
| Free Cash Flow | -45,516 | -41,737 | -144,220 | -178,883 | -7,806 | -- |
| Asset Impairment Charge | -- | -- | -- | -- | 800,000 | 0.00 |
| Change In Prepaid Assets | -- | -- | -- | -- | 0.00 | 0.00 |
| Common Stock Issuance | 34,902 | 0.00 | 0.00 | 397,690 | 0.00 | -- |
| Net Income From Continuing Operations | -472,083 | -669,169 | -89,943 | -145,939 | -839,536 | -- |
| Net Other Financing Charges | 6,017 | 11,396 | -70,467 | 43,501 | 847.00 | -- |
| Net Short Term Debt Issuance | 416.00 | -- | -- | 3,796 | 6,688 | 27,196 |
| Short Term Debt Issuance | -- | -- | -- | -- | -- | 27,196 |